drugset / Trial / NCT05019040
Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients
RandomizedSequentialOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of multiple ascending dose (MAD) of PA1010 tablets in Chinese adults with Chronic Hepatitis B.
Timeline
- Start
- 2021-09-17
- Primary completion
- 2022-11-15
- Completion
- 2022-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PA1010 | Unknown | 5 mg | — |
| Subject | PA1010 | Unknown | 10 mg | — |
| Subject | PA1010 | Unknown | 20 mg | — |